Summary
This 4-week randomised controlled trial examined whether a combined supplement of casein hydrolysate (250 mg) and yeast β-glucan (250 mg) could improve maternal immune, cardiometabolic and gastrointestinal health in 58 breastfeeding women at 4 weeks postpartum. The intervention significantly improved constipation domain scores and overall gastrointestinal symptom domain scores compared to maltodextrin control, though no effects were observed on cytokine expression or cardiometabolic parameters. The findings suggest potential for targeted nutritional support of gastrointestinal health in the early postpartum period, though larger studies are needed to confirm efficacy and explore effects on inflammation.
Regional applicability
The study was conducted with a small UK-based cohort (author affiliations suggest Irish/UK institutions), so findings are directly applicable to United Kingdom maternal nutrition practice and postpartum health contexts. However, the sample size (n=58) is modest and limits generalisability; replication in larger UK and international populations is warranted before policy or practice recommendations.
Key measures
Gastrointestinal symptoms (SAGIS tool: constipation, defaecation difficulty, urgency, diarrhoea), cytokine expression in PBMCs, cardiometabolic health parameters
Outcomes reported
The study measured gastrointestinal symptoms (constipation, defaecation difficulty, urgency, diarrhoea) using the SAGIS tool, cytokine expression in peripheral blood mononuclear cells, and cardiometabolic health markers in early postpartum breastfeeding women. The intervention improved constipation domain scores and overall gastrointestinal symptom scores compared to control after 4 weeks.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.